A simple and reproducible method for directed evolution: combination of random mutation with dITP and DNA fragmentation with endonuclease V.

Molecular Biotechnology
Zun WangHong Feng

Abstract

An alternative method to combine mutagenesis PCR with dITP and fragmentation by endonuclease V for directed evolution was developed. In comparison to the routine protocol for directed evolution, dITP was used as mutation reagent in the mutagenesis PCR. Subsequently, the incorporated dITP in the PCR products could represent as being the target of endonuclease V. Finally, the mutated dsDNA was fragmented by endonuclease V and then shuffled via assembly and reamplification as is usually done. In this study, the gene encoding kanamycin resistance has been used as reporter to verify the novel method for directed evolution. However, the mutation frequency could be easily adjusted by the amount of dITP used in the mutagenesis PCR reaction. Besides, this protocol yielded the mutation types with an obvious bias to transition substitutions as the normal error-prone PCR did. Conclusively, this novel method for directed evolution has been demonstrated to be efficient, reproducible, and easy to handle in actual practice. Using this protocol, we have successfully constructed a random mutation library for the gene encoding a serine alkaline protease.

References

Aug 1, 1992·PCR Methods and Applications·R C Cadwell, G F Joyce
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M A InnisM A Brow
Oct 25, 1994·Proceedings of the National Academy of Sciences of the United States of America·W P Stemmer
Sep 11, 1993·Nucleic Acids Research·H DierickJ J Cassiman
Jan 13, 2000·BioTechniques·O BluteauJ Zucman-Rossi
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·H KimW J Lennarz
Feb 28, 2002·Journal of Molecular Biology·John M JoernFrances H Arnold
Dec 10, 2002·Current Opinion in Chemical Biology·Haiyan Tao, Virginia W Cornish
Dec 20, 2002·Nucleic Acids Research·Kentaro Miyazaki
Jan 4, 2003·Chembiochem : a European Journal of Chemical Biology·Dongxing ZhaManfred T Reetz
Sep 2, 2003·Current Opinion in Structural Biology·Paul A Dalby
Feb 12, 2004·Nucleic Acids Research·Tuck Seng WongUlrich Schwaneberg
Jan 12, 2005·Biochemistry·Hong FengWeiguo Cao
Sep 9, 2005·Microbiology and Molecular Biology Reviews : MMBR·Ling YuanRobert Keenan
Sep 15, 2005·Journal of Bacteriology·Margaret A SmithAnn M Flower
Oct 11, 2005·Microbial Cell Factories·Edward G Hibbert, Paul A Dalby
Apr 3, 2007·Gene·Nedeljka N RosicElizabeth M J Gillam
Feb 21, 2008·Current Opinion in Chemical Biology·Shimon Bershtein, Dan S Tawfik
Jan 10, 2009·Applied Biochemistry and Biotechnology·Min-Yuan WanHong Feng

❮ Previous
Next ❯

Citations

Dec 25, 2012·Cellular and Molecular Life Sciences : CMLS·Weiguo Cao
May 8, 2013·The FEBS Journal·Anna J RuffUlrich Schwaneberg
Sep 10, 2013·Biotechnology Advances·Kang Lan Tee, Tuck Seng Wong
May 18, 2017·Chemistry : a European Journal·Elena EremeevaPiet Herdewijn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.